IRIDEX Corporation ( IRIX) - Key Metrics
IRIX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.72 | -$0.07 | $0.01 | $0.02 |
| 2026Q1 | $0.68 | -$0.03 | -$0.08 | -$0.08 |
| 2025Q4 | $0.86 | -$0.01 | $0.03 | $0.03 |
| 2025Q3 | $0.73 | -$0.09 | -$0.07 | -$0.07 |
| 2025Q2 | $0.81 | -$0.06 | -$0.02 | -$0.02 |
IRIX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.89 |
| 2026Q1 | 0% | -8.17 |
| 2025Q4 | 0% | -27.34 |
| 2025Q3 | 0% | -3.19 |
| 2025Q2 | 0% | -3.72 |
IRIX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q2 | 1.40% | 0% |
| 2026Q1 | -8.46% | 0% |
| 2025Q4 | 2.81% | 0% |
| 2025Q3 | -5.99% | 0% |
| 2025Q2 | -2.77% | 0% |
IRIX
Price: $0.66
52 week price:
Earnings Per Share: -0.20 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 10931
Ebitda: -2.8 millionMarket Capitalization: 12.1 million